Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
41.75
+0.19 (0.46%)
At close: Aug 7, 2026, 4:00 PM EDT
41.71
-0.04 (-0.10%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Celldex Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $60 | Buy | Maintains | $60 | +43.71% | Aug 7, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $68 | Buy | Maintains | $68 | +62.87% | Aug 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $61 | Buy | Reiterates | $61 | +46.11% | Aug 7, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $56 | Buy | Maintains | $56 | +34.13% | Aug 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $40 → $46 | Buy | Reiterates | $40 → $46 | +10.18% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $100 | Buy | Reiterates | $100 | +139.52% | Aug 7, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $34 → $38 | Hold | Maintains | $34 → $38 | -8.98% | Aug 7, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $7 → $72 | Buy | Reiterates | $7 → $72 | +72.46% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.